COMMUNIQUÉS West-GlobeNewswire

NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow: Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth
17/06/2026
BOCA RATON, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID: MAJI) today announced a strategic pivot, evolutionary restructuring, and operational alignment designed to [...]
HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer
17/06/2026
Pharmaceutical executive and physician with strong experience in global research and development Over 20 years’ experience in all stages of clinical development across multiple indications, including neurology and [...]
Step Pharma advances dencatistat into phase 2 clinical trial for essential thrombocythaemia
17/06/2026
Saint-Genis-Pouilly, France, 17 June 2026 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that it has advanced dencatistat, the Company’s first-in- [...]
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data [...]
Avricore Health Closes $1.254 Million Financing
17/06/2026
VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore” ) announces that, further to its news release dated May 20, 2026, the Company has closed its [...]
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
17/06/2026
Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of 100% and to repurchase $25 million of [...]
BrewDog Turns Up Father’s Day Across the U.K. with Gift-Ready Beer, Custom Cans and Dads Eat Free
17/06/2026
From standout beer gifts to nationwide bar experiences, BrewDog is bringing bold flavour and big Father’s Day energy to dads across the U.K. ELLON, Scotland, June 17, 2026 (GLOBE NEWSWIRE) -- Scottish brewer, BrewDog , [...]
Des preuves inédites montrent comment un modèle fondé sur l’entrepreneuriat peut réduire l’extrême pauvreté parmi les réfugiés
17/06/2026
De nouvelles études montrent que le programme DREAMS augmente les revenus, l’épargne et la résilience des communautés de réfugiés en Afrique de l’Est La Fondation IKEA a engagé 7,4 millions de dollars pour financer la [...]
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
17/06/2026
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development [...]
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data [...]
IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend
17/06/2026
Louvain-la-Neuve, Belgium, 17 June 2026 - At its Board meeting held yesterday in Louvain-la-Neuve, IBA (Ion Beam Applications S.A., EURONEXT) welcomed two new Board members, acknowledged the departure of outgoing [...]
IBA renforce son Conseil d’administration avec deux nominations de premier plan et annonce la date du paiement de son dividende
17/06/2026
Louvain-la-Neuve, Belgique, le 17 juin 2026 - Lors de son Conseil d’administration tenu hier à Louvain-la-Neuve, IBA (Ion Beam Applications S.A., EURONEXT) a approuvé la nomination de nouveaux membres de son Conseil d’ [...]
IBA strengthens its leadership team to support its growth
17/06/2026
Olivier Legrain, CEO of IBA, is appointed Vice-Chairman of the IBA Board of Directors and Henri de Romrée, Deputy CEO, assumes strategic and operational responsibility for all Group activities. Catherine Vandenborre is [...]
IBA déploie son équipe de direction pour accompagner son développement
17/06/2026
Olivier Legrain, CEO d'IBA, est nommé Vice-Président du Conseil d'administration d'IBA et Henri de Romrée, Deputy CEO, prend la responsabilité stratégique et opérationnelle de l'ensemble des activités du Groupe. [...]
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich
17/06/2026
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, June 17, 2026 – Kuros Biosciences (“Kuros” or the “ [...]
GuideAI Health Corp. Announces Closing of Business Combination, Subscription Receipt Offering, and Filing of Final Prospectus
17/06/2026
Not for distribution to U.S. Newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. BOSTON, June 16, 2026 (GLOBE [...]
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
16/06/2026
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has filed with the Toronto Stock [...]
Health Catalyst to Participate in Upcoming Investor Conference
16/06/2026
SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/06/2026
BRISBANE, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]

Pages